Publication | Closed Access

A novel cantharidin analog N-Benzylcantharidinamide reduces the expression of MMP-9 and invasive potentials of Hep3B via inhibiting cytosolic translocation of HuR

Cytosolic TranslocationInvasive PotentialsMedicineNovel Cantharidin AnalogAnti-cancer AgentPharmacologyCell BiologyCell SignalingNovel Therapy